Literature DB >> 28301299

Differential role for PAK1 and PAK4 during the invadopodia lifecycle.

Nicole S Nicholas1,2, Aikaterini Pipili1,2, Michaela S Lesjak1, Claire M Wells1.   

Abstract

PAK1 and PAK4 are members of the p-21 activated kinase family of serine/threonine kinases. PAK1 has previously been implicated in both the formation and disassembly of invasive cell protrusions, termed invadopodia. We recently reported a novel role for PAK4 during invadopodia maturation and confirmed a specific role for PAK1 in invadopodia formation; findings we will review here. Moreover, we found that PAK4 induction of maturation is delivered via interaction with the RhoA regulator PDZ-RhoGEF. We can now reveal that loss of PAK4 expression leads to changes in invadopodia dynamics. Ultimately we propose that PAK4 but not PAK1 is a key mediator of RhoA activity and provide further evidence that modulation of PAK4 expression levels leads to changes in RhoA activity.

Entities:  

Keywords:  PAK; RhoA; invadopodia

Mesh:

Substances:

Year:  2017        PMID: 28301299      PMCID: PMC6548287          DOI: 10.1080/21541248.2017.1295830

Source DB:  PubMed          Journal:  Small GTPases        ISSN: 2154-1248


  37 in total

1.  PAK4 and alphaPIX determine podosome size and number in macrophages through localized actin regulation.

Authors:  Alexandra Gringel; Daniel Walz; Georg Rosenberger; Audrey Minden; Kerstin Kutsche; Petra Kopp; Stefan Linder
Journal:  J Cell Physiol       Date:  2006-11       Impact factor: 6.384

2.  GEF-H1 modulates localized RhoA activation during cytokinesis under the control of mitotic kinases.

Authors:  Jörg Birkenfeld; Perihan Nalbant; Benjamin P Bohl; Olivier Pertz; Klaus M Hahn; Gary M Bokoch
Journal:  Dev Cell       Date:  2007-05       Impact factor: 12.270

3.  An allosteric kinase inhibitor binds the p21-activated kinase autoregulatory domain covalently.

Authors:  Julien Viaud; Jeffrey R Peterson
Journal:  Mol Cancer Ther       Date:  2009-09-01       Impact factor: 6.261

4.  Small-molecule p21-activated kinase inhibitor PF-3758309 is a potent inhibitor of oncogenic signaling and tumor growth.

Authors:  Brion W Murray; Chuangxing Guo; Joseph Piraino; John K Westwick; Cathy Zhang; Jane Lamerdin; Eleanor Dagostino; Daniel Knighton; Cho-Ming Loi; Michael Zager; Eugenia Kraynov; Ian Popoff; James G Christensen; Ricardo Martinez; Susan E Kephart; Joseph Marakovits; Shannon Karlicek; Simon Bergqvist; Tod Smeal
Journal:  Proc Natl Acad Sci U S A       Date:  2010-05-03       Impact factor: 11.205

5.  LCH-7749944, a novel and potent p21-activated kinase 4 inhibitor, suppresses proliferation and invasion in human gastric cancer cells.

Authors:  Jian Zhang; Jian Wang; Qiqiang Guo; Yu Wang; Ying Zhou; Huizhi Peng; Maosheng Cheng; Dongmei Zhao; Feng Li
Journal:  Cancer Lett       Date:  2011-11-13       Impact factor: 8.679

6.  PAK4: a pluripotent kinase that regulates prostate cancer cell adhesion.

Authors:  Claire M Wells; Andrew D Whale; Maddy Parsons; John R W Masters; Gareth E Jones
Journal:  J Cell Sci       Date:  2010-04-20       Impact factor: 5.285

7.  Formation of extracellular matrix-digesting invadopodia by primary aortic smooth muscle cells.

Authors:  Emilia Furmaniak-Kazmierczak; Scott W Crawley; Rhonda L Carter; Donald H Maurice; Graham P Côté
Journal:  Circ Res       Date:  2007-04-19       Impact factor: 17.367

Review 8.  Invadopodia: specialized tumor cell structures for the focal degradation of the extracellular matrix.

Authors:  Roberto Buccione; Giusi Caldieri; Inmaculada Ayala
Journal:  Cancer Metastasis Rev       Date:  2009-06       Impact factor: 9.264

Review 9.  Role of p-21-activated kinases in cancer progression.

Authors:  Helen King; Nicole S Nicholas; Claire M Wells
Journal:  Int Rev Cell Mol Biol       Date:  2014       Impact factor: 6.813

10.  Integrin-matrix clusters form podosome-like adhesions in the absence of traction forces.

Authors:  Cheng-han Yu; Nisha Bte Mohd Rafiq; Anitha Krishnasamy; Kevin L Hartman; Gareth E Jones; Alexander D Bershadsky; Michael P Sheetz
Journal:  Cell Rep       Date:  2013-11-27       Impact factor: 9.423

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.